Kangla Tsung

2.3k total citations
47 papers, 1.9k citations indexed

About

Kangla Tsung is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Kangla Tsung has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 25 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Kangla Tsung's work include Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (16 papers) and Immune Cell Function and Interaction (12 papers). Kangla Tsung is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (16 papers) and Immune Cell Function and Interaction (12 papers). Kangla Tsung collaborates with scholars based in United States, Switzerland and Australia. Kangla Tsung's co-authors include Jeffrey A. Norton, Masayori Inouye, Jennifer B. Meko, Nicholas P. Restifo, R E Brissette, Willem W. Overwijk, Bernard Moss, Miles W. Carroll, Kazuhiro Ikenaka and Steven A. Rosenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Kangla Tsung

44 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kangla Tsung United States 20 1.1k 716 687 596 155 47 1.9k
Denise R. Shaw United States 21 493 0.4× 858 1.2× 392 0.6× 298 0.5× 76 0.5× 34 1.4k
Martin Schleef Germany 24 446 0.4× 1.4k 1.9× 724 1.1× 321 0.5× 137 0.9× 60 2.0k
Mary J. Tevethia United States 28 677 0.6× 721 1.0× 644 0.9× 964 1.6× 76 0.5× 70 2.1k
James J. Crute United States 18 663 0.6× 829 1.2× 430 0.6× 363 0.6× 73 0.5× 25 2.1k
Javier Hernández France 26 1.2k 1.0× 668 0.9× 182 0.3× 470 0.8× 121 0.8× 49 2.0k
Steven J. Werden United States 19 345 0.3× 813 1.1× 478 0.7× 574 1.0× 74 0.5× 23 1.6k
Caroline E. Lilley United States 20 450 0.4× 1.1k 1.6× 674 1.0× 471 0.8× 83 0.5× 23 2.2k
Pascale Duplay Canada 19 603 0.5× 643 0.9× 284 0.4× 219 0.4× 60 0.4× 31 1.3k
Alice I. Sato United States 9 1.4k 1.3× 470 0.7× 126 0.2× 555 0.9× 56 0.4× 13 1.9k
Iyoko Katoh Japan 21 408 0.4× 1.2k 1.7× 243 0.4× 616 1.0× 271 1.7× 40 2.2k

Countries citing papers authored by Kangla Tsung

Since Specialization
Citations

This map shows the geographic impact of Kangla Tsung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangla Tsung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangla Tsung more than expected).

Fields of papers citing papers by Kangla Tsung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangla Tsung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangla Tsung. The network helps show where Kangla Tsung may publish in the future.

Co-authorship network of co-authors of Kangla Tsung

This figure shows the co-authorship network connecting the top 25 collaborators of Kangla Tsung. A scholar is included among the top collaborators of Kangla Tsung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangla Tsung. Kangla Tsung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsung, Kangla, et al.. (2023). On the Individualized Cancer Management. 8(11).
2.
3.
Guo, Huiqin & Kangla Tsung. (2017). Tumor reductive therapies and antitumor immunity. Oncotarget. 8(33). 55736–55749. 11 indexed citations
4.
Tsung, Kangla, et al.. (2016). Copulatory plugs inhibit the reproductive success of rival males. Journal of Evolutionary Biology. 29(11). 2289–2296. 18 indexed citations
5.
Feng, Dongdong, et al.. (2013). Preexisting antitumor immunity augments the antitumor effects of chemotherapy. Cancer Immunology Immunotherapy. 62(6). 1061–1071. 12 indexed citations
6.
Norton, Jeffrey A., et al.. (2005). Inhibition of Host Signal Transducer and Activator of Transcription Factor 6 Results in Cure With Cyclophosphamide and Interleukin 12 Immunotherapy. Annals of Surgical Oncology. 13(1). 118–124. 5 indexed citations
7.
Hiramoto, Jade S., Kangla Tsung, Melanie Bedolli, Jeffrey A. Norton, & Ryutaro Hirose. (2004). Antitumor immunity induced by dendritic cell-based vaccination is dependent on interferon-γ and interleukin-12. Journal of Surgical Research. 116(1). 64–69. 11 indexed citations
8.
Tsung, Kangla, et al.. (2003). Cure of an Established Nonimmunogenic Tumor, SCC VII, With a Novel Interleukin 12–Based Immunotherapy Regimen in C3H Mice. Archives of Otolaryngology - Head and Neck Surgery. 129(7). 786–786. 15 indexed citations
9.
10.
Tsung, Kangla, et al.. (2001). Pre-Existing Tumor-Sensitized T Cells Are Essential for Eradication of Established Tumors by IL-12 and Cyclophosphamide Plus IL-12. The Journal of Immunology. 167(12). 6765–6772. 39 indexed citations
11.
Tsung, Kangla, et al.. (1998). Vaccinia Virus for Human Gene Therapy. Surgical Oncology Clinics of North America. 7(3). 575–588. 23 indexed citations
12.
Carroll, Miles W., Bernard Moss, Willem W. Overwijk, et al.. (1998). Construction and Characterization of a Triple-Recombinant Vaccinia Virus Encoding B7-1, Interleukin 12, and a Model Tumor Antigen. JNCI Journal of the National Cancer Institute. 90(24). 1881–1887. 39 indexed citations
13.
14.
Tsung, Kangla, et al.. (1996). Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. Journal of Virology. 70(1). 165–171. 112 indexed citations
15.
Marti, Walter R., et al.. (1996). Non-replicating recombinant vaccinia virus encoding murine B-7 molecules elicits effective costimulation of naive CD4+ splenocytes in vitro. Journal of General Virology. 77(12). 3121–3125. 7 indexed citations
16.
Bronte, Vincenzo, et al.. (1995). IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.. The Journal of Immunology. 154(10). 5282–5292. 104 indexed citations
17.
Tsung, Kangla, et al.. (1995). In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1beta*. Surgery. 118(2). 185–191. 26 indexed citations
18.
Tsung, Kangla, et al.. (1995). Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1β. Annals of Surgical Oncology. 2(2). 151–159. 18 indexed citations
19.
Brissette, R E, Kangla Tsung, & Masayori Inouye. (1992). Mutations in a central highly conserved non-DNA-binding region of OmpR, an Escherichia coli transcriptional activator, influence its DNA-binding ability. Journal of Bacteriology. 174(15). 4907–4912. 11 indexed citations
20.
Ikenaka, Kazuhiro, et al.. (1988). A dominant mutation in Escherichia coli OmpR lies within a domain which is highly conserved in a large family of bacterial regulatory proteins. Molecular and General Genetics MGG. 211(3). 538–540. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denise R. Shaw Breakdown of academic impact, for papers by Martin Schleef Breakdown of academic impact, for papers by Mary J. Tevethia Breakdown of academic impact, for papers by James J. Crute Breakdown of academic impact, for papers by Javier Hernández Breakdown of academic impact, for papers by Steven J. Werden Breakdown of academic impact, for papers by Caroline E. Lilley Breakdown of academic impact, for papers by Pascale Duplay Breakdown of academic impact, for papers by Alice I. Sato Breakdown of academic impact, for papers by Iyoko Katoh
Rankless by CCL
2026